The Marketplace Report: More FDA Woes for Pfizer NPR's Alex Chadwick talks to Tess Vigeland of Marketplace about drug maker Pfizer's latest woes. The government took the Pfizer drug Bextra off the market on Thursday, and ordered that the strongest possible warning be put on Celebrex, another of the company's pain-killing prescription drugs.

The Marketplace Report: More FDA Woes for Pfizer

The Marketplace Report: More FDA Woes for Pfizer

  • Download
  • <iframe src="https://www.npr.org/player/embed/4581065/4581066" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

NPR's Alex Chadwick talks to Tess Vigeland of Marketplace about drug maker Pfizer's latest woes. The government took the Pfizer drug Bextra off the market on Thursday, and ordered that the strongest possible warning be put on Celebrex, another of the company's pain-killing prescription drugs.